THE INTERSECTION OF BRAIN SCIENCE & HUMAN POTENTIALPartner with us
neurofeedback.com
The newsletter
← Research & Evidence
MixedFull-text technical validation with same-day test-retest and consumer-versus-research-grade cross-device comparisons

Evaluation of PainWaive: a consumer-grade EEG headset for remote EEG monitoring and neurofeedback research in chronic pain

Published November 6, 2026. In 80 healthy adults, the two-channel PainWaive headset produced generally stable repeated measurements for alpha power and peak alpha frequency, while beta and theta reliability was less consistent. Agreement with a research-grade EEG system was strong for overall spectral shape but only moderate to good for alpha measures and weaker for beta and theta. Eight adults with chronic pain also completed repeated home recordings, but those data test measurement reliability, not whether the system reduces pain or whether neurofeedback is effective.

Chowdhury NS, Rawsthorne J, Hesam-Shariati N, Quidé Y, Alexander L, Ermolenko E, McIntyre A, Restrepo S, Chen K, Lin CT, Newton-John T, Middleton JW, Craig A, Jensen MP, McAuley JH, Gustin SM.
NPJ digital medicine · Publication date: 2026-11-06
Added to site: 2026-11-11
DOI: 10.1038/s41746-026-03424-5

Published November 6, 2026. Added to Neurofeedback.com November 11, 2026 after comparison with fresh and reserve candidates. The source publication date is separate from the site addition date.

Modalities
Electroencephalography, Neurofeedback, Remote monitoring
Clinical focus
Consumer-grade EEG validation, Chronic pain research, Home-based measurement
Population
Eighty healthy adults in the laboratory validation and eight adults with chronic pain in two small home-use single-case datasets
Sample
80 healthy adults, including 47 women, plus 8 adults with chronic pain who completed 20 home sessions each for 160 chronic-pain sessions
Intervention / method
Healthy participants completed two same-day eyes-open and eyes-closed resting EEG sessions with the two-channel PainWaive system and a research-grade LiveAmp system. Four adults with neuropathic eye pain and four with chronic low back pain completed 20 repeated home sessions each. Analyses compared spectral shape, alpha, beta, theta and peak alpha frequency across repeated sessions, devices and preprocessing pipelines.
Comparator
Research-grade LiveAmp EEG for cross-device agreement, plus repeated PainWaive recordings for within-device reliability

Clinician summary

Same-day PainWaive test-retest ICCs were good to excellent for alpha power and peak alpha frequency, approximately 0.72 to 0.93, and moderate to good for beta and theta, approximately 0.42 to 0.76. Cross-device spectral-shape correlations exceeded 0.91, while agreement for alpha and peak alpha frequency was approximately 0.53 to 0.74 and for beta and theta approximately 0.16 to 0.51, with sensitivity to preprocessing. Pooled within-session reliability across 160 chronic-pain home sessions was generally good to excellent, but individual reliability varied. These are technical performance results, not clinical outcomes.

How to interpret the findings

The laboratory work tested resting-state EEG only and does not establish performance during active neurofeedback, task-evoked recording or movement. The consumer system used only two central scalp channels, had no independent ground-truth signal and showed pipeline-dependent cross-device agreement, especially for beta and theta. The healthy sample was young and may not generalize to clinical populations. The chronic-pain component included only eight people, used unblinded single-case datasets and did not test symptom efficacy in this validation analysis. Reliable measurement does not establish that a protocol improves pain or another health outcome.

Equipment and disclosures

The study evaluated the in-house PainWaive two-channel EEG system using central C1 and C2 placements and compared it with a research-grade LiveAmp system. This technical comparison does not establish regulatory status, clinical effectiveness or superiority over other devices. No equipment is attributed to BrainMaster.

Supported by a National Health and Medical Research Council Ideas Grant and a Rebecca L. Cooper Medical Research Foundation Fellowship awarded to Sylvia M. Gustin; the funders reportedly had no role in study design, data collection, manuscript preparation or publication. The authors declared no competing interests. No correction, retraction or expression-of-concern relation appeared in the checked PubMed record, publisher page or bounded DOI and title searches on November 11, 2026. The full text is CC BY-NC-ND 4.0. AI-assisted source review for Neurofeedback.com, not independent human clinical review.

Related evidence

Compare findings from the same clinical area, including mixed results.

Full text checked · Checked 2026-11-11

Summary prepared with AI assistance. Source verification does not imply an independent replication or a clinician's endorsement. Read our review method.